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Abstract
Prior studies in patients following bariatric surgery have demonstrated an associated reduction in lean
muscle mass concomitant with total weight loss. Less described are any changes of skeletal muscular
strength following bariatric surgery and if changes in strength are propmiional to total weight loss.
Purpose: To describe changes in upper and lower body strength following weight loss surgery. Methods:
Seven subjects (age (yr) = 48 ±13; weight (kg)= 137.4 ± 5.4; BMI (kg/m2 ) =50 ±5) who underwent
laparoscopic bariatric surgery at Henry Ford Hospital (6 Roux-en-Y bypass and 1 vetiical sleeve) were
assessed. Within 30 days prior to surgery upper and lower body strength were assessed, respectively, by
performing a one repetition max test on an isotonic chest press (CP) machine (Cybex) and a single-leg
knee extension (KE) using an isokinetic dynamometer (Biodex). Strength tests were repeated three
months following surgery. AN OVA tests were used to compare differences in strength between baseline,
three months, and six months. Results: At three months there was a 20% weight loss (p < 0.001), and 25%
reduction ofBMI (p < 0.001). Overall strength was reduced at three months. The absolute decrease in
strength was significant only for peak torque at 120° · sec·1 • All other strength measures trended towards
significance. However, when body weight was controlled for, relative strength for all tests were no
different before and after bariatric surgery. Conclusion: This preliminary data shows reductions in
absolute strength following weight loss surgery, are related to total weight loss. Future studies should
examine if these changes persist beyond three months post surgery as well as if a post-operative
strength-training program can minimize this impact.
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ABSTRACT
Reductions in Muscular Strength Three and Six Months Following Bariatric Surgery Are
Proportional To Absolute Weight Loss

Prior studies in patients following bariatric surgery have demonstrated an associated
reduction in lean muscle mass concomitant with total weight loss. Less described are any
changes of skeletal muscular strength following bariatric surgery and if changes in strength
are propmiional to total weight loss. Purpose: To describe changes in upper and lower body
strength following weight loss surgery. Methods: Seven subjects (age (yr) = 48 ±13; weight
(kg)= 137.4 ± 5.4; BMI (kg/m2) =50 ±5) who underwent laparoscopic bariatric surgery at
Henry Ford Hospital (6 Roux-en-Y bypass and 1 vetiical sleeve) were assessed. Within 30
days prior to surgery upper and lower body strength were assessed, respectively, by
performing a one repetition max test on an isotonic chest press (CP) machine (Cybex) and a
single-leg knee extension (KE) using an isokinetic dynamometer (Biodex). Strength tests
were repeated three months following surgery. AN OVA tests were used to compare
differences in strength between baseline, three months, and six months. Results: At three
months there was a 20% weight loss (p < 0.001), and 25% reduction ofBMI (p < 0.001).
Overall strength was reduced at three months. The absolute decrease in strength was
significant only for peak torque at 120° · sec· 1• All other strength measures trended towards
significance. However, when body weight was controlled for, relative strength for all tests
were no different before and after bariatric surgery. Conclusion: This preliminary data
shows reductions in absolute strength following weight loss surgery, are related to total
weight loss. Future studies should examine if these changes persist beyond three months post
surgery as well as if a post-operative strength-training program can minimize this impact.
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Introduction
There is an epidemic of overweight and obesity in the United States. The prevalence
of excess weight is increasing rapidly across the country, and today close to 65% of the adult
population is overweight or obese. Comparing the period 1976-1980 with 1999 -2000the
prevalence of ovetweight [body mass index (BMI) 25kg/m2] has increased by 40% (from
46.0% to 64.5%) and the prevalence of obesity (BMI30 kg/m2) has risen by 110%
(from 14.5% to 30.5%). There is an alarming increase in weight among the youth. More than
10% of 2- to 5-yr-o1ds and 15% of 6- to 19-yr-olds are overweight (BMI 95th percentile for
age and gender). This represents a near doubling of over-weight children and a near-tripling
of overweight adolescents over the last two decades. Whereas some segments of the
population are more likely to be overweight or obese than others, people of all ages, races,
ethnicities, socioeconomic levels, and geographic areas are experiencing a substantial
increase in weight (Stein & Colditz, 2004).
Obesity has become an important public health problem in industrialized countries
t1n·oughout the world. International data indicate that the epidemic is not isolated to the
United States but is in fact a global health problem. The prevalence of obesity is rising in
other developed and affluent countries and is now spreading to less affluent countries (Stein
& Colditz, 2004 ).

The body mass index (BMI =weight (in kg/heighe [in m2]) is the primary
measmement used to categorize obese patients. Excess body weight (EBW) is defined as the
amount of weight that is in excess of the ideal body weight (IBW). Ideal body weight is
conventionally determined by the Metropolitan Life Tables, or as a BMI of25 kg/m2 .
In1991, the National Institutes of Health defined morbid obesity as a BMI of~ 35 kg/m2 and
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severe, obesity-related comorbidity as a BMI of2: 40 kg/m2 (Brethauer, Kashyap, & Schauer,
2000-2013).
Obesity is usually developed from the interactions of excessive caloric intake, eating
the wrong types of foods, lack of exercise, and poor portion control. Obesity and overweight
results from the interaction of many factors, including genetic, metabolic, behavioral, and
environmental influences. This increase suggests that behavioral and environmental
influences, rather than biological changes have contributed to the epidemic. Increased
energy consumption with decreased energy expenditure, or a combination of both of these
has led to a positive energy balance and a marked increase in weight in society. (Brethauer,
Kashyap, & Schauer, 2000-2013)More than 60% of the population does not participate in
some form of regular physical activity with about 25% being completely sedentary. Physical
activity in schools has decreased or ceased due to budget cuts and economic downfall.
Almost half of young Americans between the ages of twelve and twenty-one are not
moderately active on a regular basis (Stein & Colditz, 2004).
Categorv
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Recent evidence reporting that obesity is a major risk factor for many diseases and is
associated with significant morbidity and mortality. Obesity is a chronic (long-term) disease
that is increasing in frequency. More than half of American adults are overweight. Nearly
one third are obese (Saber Alan: Hale & Murr, 2013). Obesity is the second leading cause of
preventable deaths in the United States, after cigarette smoking, despite expenditures of over
$45 billion annually on weight loss products (Brethauer, Kashyap, & Schauer, 2000-2013).
People who are obese have much higher risks of many serious health problems than
nonobese people. Obesity affects every system of the body. Obesity increases the relative
risk of 30 serious medical conditions including diabetes, hypertension, obstructive sleep
apnea and pulmonary hypertension, heart disease, stroke, blood clots, deep venous
thrombosis, and pulmonary emboli, fatty liver disease and nonalcoholic steatohepatitis,
gastroesophageal reflux disease, urinary incontinence, osteoarthritis, gallstones, colon cancer,
endometrial cancer, and depression (Saber Alan: Hale & Murr, 2013).
Conventional weight loss programs and medication have modest results with an
average of 5-10% weight loss and poor long-term results. Bariatric surgery is currently the
only modality that provides a significant, sustained weight loss for the patient who is
morbidly obese, with resultant improvement in obesity-related comorbidities (Buchwald, et
al., 2004). Weight loss surgery (bariatric surgery) is the only treatment of obesity resulting on
average in> 15% docmnented weight loss over ten years (Bray and Bouchard 2004).
The existing body of research discussing postoperative weight loss, fat free mass, lean
muscle mass, and the problems associated with various surgical procedures are extensive.
There has not been any other research that specifically correlates muscular strength and
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relative strength in bariatric patients. However, there have been several studies on the impact
on bone density, lean muscle mass and fat free mass.
A recent study from Zalesinet al.(2010), found that patients that lost weight the fastest
appeared to have also had accelerated losses of both lean and fat mass. This study evaluated
the differential rates of fat and lean tissue losses in morbidly obese patients who underwent
Roux-en-Y gastric bypass surgery. Body composition was also assessed using whole-body
dual energy X-ray absorptiometry (DXA) perfmmed at two time points in the postoperative
period. There were thirty-two patients in the study of which 25 were women and seven were
men. During the study patients were encouraged to gradually increase aerobic physical
activity after surgery and begin resistance training at six weeks postoperatively, however this
did not seem to have any significant impact on the study. Only three of the 32 patients
maintained or gained muscle mass during the postsurgery follow up. All three of the patients
stated they had been regularly exercising and two of them were participating in resistance
training. Ofthe other 29 patients, 52% of them had stated that they were participating in
some type of endurance exercise and strength training and 86% of them had lost lean body
mass (Zalesin, et al., 20 I 0).
In another study from Buchwald et al., there was a systemic review of multiple
studies. There were a total of 136 fully extracted studies, which included 91 overlapping
patient populations, were included for a total of 22,094 patients. Nineteen percent of the
patients were men and 72.6% of the patients were women, with a mean average age of 39
years. The objective of this study was to analyze the impact ofbariatric surgery on comorbid
conditions such as diabetes, hyperlipidemia, hypertension, and sleep apnea. The study also
looked into the impact on healthcare economics and the impact of disease. The evidence
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showed that patients who have had bariatric surgery weight loss in excess of 45 kg obtained
relief from fatal comorbid diseases, an improved appearance, and an improved social and
economic opportunities. A substantial majority of patients with diabetes, hypertension,
hyperlipidemia, and obstructive sleep apnea experienced complete resolution or
improvements in their condition (Buchwald, eta!., 2004).
This study focused on two specific types of bariatric surgery, the Roux -en-Y (RNY),
and the Vertical Sleeve Gastrectomy. TheRoux en-Y (RNY) RNY gastric bypass surgery is
considered to be the "gold standard" in gastric bypass surgeries. Formerly called roux-en-Y,
gastric bypass bariatric surgery is the most commonly performed bariatric procedure. In this
procedure, the stomach is separated into two sections. Six small incisions are made to allow
insertion of a small scope that is connected to a video camera and the tools needed to perform
the operation. The upper part is made into a very small pouch that holds one to two ounces
initially. It is about the size of your thumb. This limits the amount of food that can be eaten
at one time. It also provides a feeling of fullness and satisfaction with smaller portions of
food. A normal stomach holds 40 to 50 ounces and is roughly the size of a person's
head. The small pouch is at the bottom of the esophagus and is very resistant to
stretching. The lower part of the stomach is not removed. This part of the stomach no longer
receives food. Nothing enters it but it does still produce gastric juices, which aids the
digestion process by eventually joining with the food in the small intestines. These two parts
of the stomach are completely separated and .are closed by a method of stapling and sewing
to eliminate the chance of leaks. A leak is a very rare and serious condition allowing food to
enter the abdominal cavity causing infection. Scar tissue eventually forms at the stapled and
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sewn area so that the pouch and stomach are permanently separated and sealed (Thompson,
2000- 20 13).
During gastric bypass bariatric surgery, a section of the small intestine called the
jejunum is then pulled up to directly connect to the small stomach pouch. The other end of
the small intestine is surgically reconnected at a point further down the small intestine. The
shape of the intestine now somewhat resembles a "Y." When food is eaten, it enters the new
stomach, then travels into the lower part of the intestine, bypassing the lower stomach and
upper pmi of the intestine.
A major benefit of this rerouting is that the hormones promoting poor blood sugar

control are almost innnediately affected, often allowing patients to significantly reduce or
eliminate their diabetes medications immediately after surgery. In addition, gastric bypass
surgery seems to diminish the appetite and
Because the body absorbs fewer

promote satiety or fullness.

calories and nutrients, patients are at
increased risk for nutritional
deficiencies. Therefore, after gastric
bypass surgery, it will be impmiant to
follow a physician's guidelines for
nutritional supplementation (Buchwald

Roux·en·Y stomach bypass:
large portion of stomach
and duodenum
are bypassed

H, 2004).

(Zieve & Rogers, 2013)
http://www.nlm.nih.gov/medlineplus/ency/imagepages/19268.htm
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The sleeve gastrectomy, also known as a vertical sleeve gastrectomy or gastric sleeve
procedme is a newer procedme in which the bariatric smgeon recreates the size and shape of
the stomach, reducing how much can be eaten at one time. It is irreversible. In gastric sleeve
surgery, the bariatric surgeon makes six small incisions to allow inse1iion of a small scope
that is connected to a video camera and the tools needed to perform the operation. The
smgeon then staples and divides the stomach, removing about 85 percent of it. The outer
margin of the stomach is removed to restrict food intake, leaving a sleeve of stomach,
roughly the size and shape of a banana, and the pylorus, the muscle that controls emptying of
food from the stomach into the intestine. A sleeve gastrectomy is a purely restrictive
procedme (Saber Alan: Hale & Mun·, 2013).
It is important to note that the part of the stomach that is removed is responsible for

secreting ghrelin, a hormone that causes feeling of hunger. As a result, patients report less
hunger after the procedure. Additional benefits of gastric sleeve surgery include a minimized

risk of protein and vitamin
deficiency following the smgery
and a minimized risk of intestinal
obstruction, as the intestines are not
rerouted. The disadvantages of
gastric sleeve bariatric surgery
include a possibility of slow or
inadequate weight loss as well as

(Laparoscopic Sleeve Gastrectomy, 2012)

possible leaks and other

http://bariatric.surgery.ucsf.edu/conditions--

complications from stapling (Shabir

procedmes/laparoscopic-sleeve-gastrectomy .aspx

Bhimji, 2013).
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According to Henry Ford Hospital, in the state of Michigan, the average three-year
excess weight loss for bariatric patients is 61%. As bariatric patients are going through their
weight loss, not all weight loss is fat as patients are also losing muscle. After having
bariatric surgery, the body transforms into what we call a catabolic or breakdown state. This
is perceived by the body as being in a starvation state and by trying to combat starvation, the
body will hoard its precious fat until any other usable fuel has been burned. In general the
body will prefer to use muscle as energy before consuming fat. This is why, if muscle is not
regularly used (as in regular exercise), more muscle will be consumed to meet energy needs.
Loss of muscle effects strength and can also impact health as it relates to bone/mineral
health, fall risk, and quality oflife (Shabir Bhimji, 2013).

Purpose
The purpose of this study is to describe absolute and relative changes in muscular
strength at three following bariatric surgery. Absolute strength is defined as the maximum
amount of force that is generated with a single effort. Often measured by performing alrepetition maximum (lRM) test. Relative strength is the amount of force that someone can
exert in relation to his or her body size or weight. The general quantification of relative
strength is the absolute muscular strength for a given exercise divided by body weight.

Methods
The subjects of this study were recruited via informational meeting following the
approval of the IRB Review board of Henry Ford Hospital and the College of Health and
Human Services (CHHS) Human Subjects Review Committee of Eastern Michigan
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University. Subjects were recruited from the Hem-y Ford Bariatric surgery program prior to
surge1-y. During enrollment, subjects were given a packet that included a letter of recruitment,
confidentiality statement, consent form, Heart Smart nutrition survey, bariatric exercise
questionnaire, food diaq, and a synopsis of the project and protocols for each of the
physiological tests they would be participating in. Exclusion Criteria included orthopedic
limitations (knee/shoulder), weight greater than 450 pounds, heart failure with an ejection
fraction less than 40%, and uncontrolled hypertension or diabetes. Subjects consisted of eight
females and one male.
There were eight subjects who had the RNY and one subject who had the Sleeve
bariatric surgery procedure. The subjects were between the ages of 3 9 and 64 years of age
with an average and standard deviation of 51 ::!;13. All subjects were between 122 kg and 149
kg in weight with an average of 135.33±3.32 (units). All subjects had a body mass index
(BMI) between 44 and 52 and an average of 48.39::!; 4.36 (units). Body mass index is
calculated as weight in kilograms divided by the square of the height in meters. All subjects
had a mid upper arm circumference (MUAC) between 37 and 44 with an average of 40.44::!;
3.16 (units). MUAC is the circumference of the left upper arm, measured at the mid-point
between the tip of the shoulder and the tip of the elbow (olecranon process and the
acromion). All subjects had a block score between 7 and 17 with an average of 12.11 ::!; 4.57
(units). All25subjects participated in the physiological testing and in data collection. Within
one month of surgery, subjects were accessed for both upper body and lower body strength.
Testing consisted of completing a lRM test on an isotonic chest press (CP) machine (Cybex)
and a single-leg isokinetic knee extension (KE) (Biodex).
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Upper body strength was measured utilizing the 1-repetetion maximum test on a
seated chest press. The 1RM requires a person to exert maximally on a selected weight,
chosen as close as possible to the person's expected 1 RM weight. If the person cannot lift it
with correct form, then a lower weight is tried after a two-minute rest interval. After the twominute rest interval, a small additional weight is added, and the person tries again. This
process is repeated until only one repetition is possible for a maximum of five tries.
Movements were performed in a seated, upright position, straddling the bench facing the
machine. The hands were positioned on the handgrips slightly wider than shoulder width.
The palms were facing forward, grasping the handgrip in an open, relaxed manner. Subjects
were instructed to slide the hips forward until the shoulders and the hips were aligned
vertically under the handgrips. During the lift, the subjects pressed the handgrips upward
until the arms were near full extension,
exhaling and without arching the
back. The subjects then returned
the weight slowly back to the
starting position. The lift was
performed in a controlled manner.
The subject's feet remained in
contact with the floor during the
entire lift.
(Chest Press, 2013)
http://www. teachpe.com/ strengthening/m-chest_press. php
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A single-leg isokinetic knee extension (e.g. Biodex, Cybex) was used to determine
lower body strength. Isokinetic exercise is performed with a specialized apparatus that
provides variable resistance so that no matter how much effort is exerted the movement is
conducted at a constant speed. The Biodex System is an isolated joint isokinetic system that
allows one to measure the amount of strength produced at different velocities. For this study,
the speeds were set at place at 60, 120, and 180 degrees of movement per second. Isokinetic
muscle loading consists of fixed speed of movement and resistance that is variable, and most
importantly, totally accommodating. Because the resistance is accommodating, it allows for
maximal muscle loading throughout the entire range of motion. The subject is positioned so
that the body movement to be measured is isolated. The equipment is then set at different
speeds and the force applied can be measured throughout the range of movement. The results
were reported at different speeds so that a speed/strength/power relationship can be
identified.

Statistical Analysis
Analysis of variance (ANOVA) is a collection of statistical models used to analyze
the differences between group means and their associated procedures (such as "variation"
among and between groups), in which the observed variance in a particular variable
partitioned into components attributable to different sources of variation. In its simplest form,
AN OVA provides a statistical test of whether or not the means of several groups are all
equal, and therefore generalizes t-test to more than two groups. Doing multiple two-sample ttests would result in an increased chance of committing a type I enor. For this reason,
ANOVAs are useful in comparing (testing) three or more means (groups or variables) for
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statistical significance (Analysis of Variance (ANOVA), 2013). A repeated measures
ANOV A test with Bonferroni pairwise comparisons were used to determine differences in
strength measures between baseline, 3 months, and 6 months. (IBM Corp. Released 2012.
IBM SPSS Statistics for Mac, Version 21.0. Armonk, NY).

Results
According to the data collected from the exercise logs completed by the patients, the
majority of the bariatric patients were sedentary. Some reported very minor aerobic or
resistance training activities, but a better comparison can be found with the pre vs. post
surgery muscular strength analyses included in this study. All of the subjects reported some
type of planned exercise between baseline and three months post surgery. An average of
74% reported walking as their main exercise, while only 26% reported participating in
resistance h·aining >2 days per week. The raw data for each subject for absolute strength at
60, 120 and 180 degrees per second along with an average of all subjects is included in the
appendices.
There were significant changes in body composition between baseline and three
months and less significant changes between three and six months. There was a 21.04%
excess weight loss at three months and26.1 % excess weight loss at six months. There was a
21.5 %reduction in BMI at three months and a 26.2% reduction of BMI at 6 months. There
was a 14.5% difference in MUAC at three months and a 20.5% difference at 6 months.
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Results: Body composition
changes
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The figure below displaying absolute peak torque over time reports that overall strength of
the patients was significantly reduced at three months for the speed at 60 degrees and 120
degrees per second. There was not significant difference between three and six months.
Further post-hoc pairwise comparisons of absolute peak torque showed no difference
between three months and six months torque.

Results:Absolute
Peak Torque
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The figure below displaying relative peak torque over time reports that, although
absolute peak torque goes down from baseline to three months, at three to six months relative
peak torque remains unchanged. The study reports that patients displayed a significantly
higher absolute power but lower relative peak torque and power. This is indicated although
the actual strength has decreased, the relative strength has not dramatically changed because
the amount of weight has decreased. For example, when a person is 300 pounds and
performing a chest press they are able to press 250 pounds. The person loses 100 pounds and
can only press 225 pounds after the weight loss. With absolute peak torque the person was
able to lift 50 pounds above their body weight, but losing the 100 pounds although the person
is lifting a lighter weight at 225, the persons relative peak torque is higher than the persons
absolute because their body weight is also lower so this person is actually able to life more.
Absolute in this case refers to strength where relative is the strength divided by the weight.

Results: Relative Peak Torque
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For the next two for the chest press tests for absolute and relative peak torque,
although absolute peak torque decreases from baseline to three months, relative peak torque
remains unchanged at three to six months. This study reports that patients displayed a
significantly higher absolute power but lower relative peak torque and power. Further posthoc pairwise comparisons of relative chest press results showed very little difference between
three to six months. The biggest dereference was between baseline and three months.

Results: Absolute Chest Press

Results
Relative Chest Press
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There was no significant difference between baseline and 6 months for chest press.
The increase in relative chest press at 6 months is solely driven by the fact that the patient
lost weight from the surgery versus any absolute strength increases.

Discussion
This study provides a unique opportunity to look at muscular strength and how if
affects bariatric patients with respect to absolute, relative peak torque, fatigue curve, BMI,
MUAC, and the difference in weight (kg) at baseline, three months and six months post
surgery. With the exception of relative peak torque, the results showed a big difference in
each of these areas between baseline and three months with less significant change between
three and six months. The relative peak torque did not report any significant changes
between baseline and six months. These changes are all contributed to a drop in weight in the
subjects.
Although each patient filled out questionnaires in regard to exercise, dietary intake,
and nutrition, there maintains room for error in knowing whether or not the patient was
accurate in their reporting of the data. It is unclear as to whether this had a negative impact
on the outcome of the data.
It is has been established in a study by (Zalesin, eta!., 20!0) that the associated

changes in body composition is important because the maintenance or enhancement oflean
mass is associated with augmented muscular strength and endurance. The study demonstrated
that t hose patients who experienced the greatest rate of weight loss after bariatric surgery did
so at the expense of losing relatively more lean body mass and fat tissue.
These findings contribute significantly to the research field as this is a pilot study and
there are not any other studies that have been conducted specifically on the bariatric
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population. As bariatric surgery becomes more prevalent it is important to understand how
the changes in muscular strength affect the subjects ability to maintain their weight loss.
This study will aid in helping personal trainers, exercise physiologists and other allied
professionals when developing a post surgery exercise, strength and conditioning plan.
This study is a pilot study that can open the door for continued research on the
relationship between lean muscle mass, metabolism, absorption, and protein intake in
relationship with muscular strength. As there is not any current research on muscular
strength in bariatric patients further investigation could be continued for a longer time fi·ame
to see ifthe changes in relative peak torque shifts after a certain period of time.

Conclusion
Bariatric surgery provides a unique opportunity to study the differences between
absolute and relative strength. This preliminary data shows reductions in absolute strength
following weight loss surgery are related to total weight loss. Although the patients' absolute
strength decreased from baseline to six months, their relative strength did not decrease
according to preliminary data. This was attenuated to the significant drop in weight. The
possible long-term consequence of significant muscle loss in this population remains unclear.
Strength training may attenuate the loss oflean muscle mass (LMM) and further studies are
needed in this area of research.
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Appendix C

HFHS Bariatric Exercise Study
We would like to invite
you to assist us with our
effort to better
understand bariatric
surgery outcomes and
how the surgery relates to
any possible changes in
muscular strength.

~PURPOSE:

Describe changes in muscular strength pre-surgery, and at
three and six months following bariatric surgery. In addition,
we propose to examine the relationship between strength
and several potential co-variants.
~

WHO CAN PARTICIPATE:
Any bariatric patient within the Henry Ford Health System
(i.e. Detroit, West Bloomfield, Macomb, Warren, and
Wyandotte).* While we anticipate that most will be eligible, there
are some exclusion criteria.

~
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COMPENSATION:
For the study you will be compensated by receiving a one
month free membership to our PREVENT program.

Name:

Date: _ __

Heart Smart® Nutrition Survey
These questions are to find out how often you eat each of these food items. Look
carefully at the choices at the top of each column. Notice that some of the choices are per
month, and others are per week. When answering, think about your eating habits over the past
month. About how often do you eat each of these foods? Please put an "X" in the
appropriate box.

Meats and Snacks

Hamburgers, ground beef, meat burritos, tacos
Beef or pork, such as steaks, roasts, ribs or in
sandwiches
Fried Chicken
Hot Dogs or Polish or Italian sausage
Cold Cuts lunch meats ham !not low-fat)
Bacon or breakfast sausage
Salad dressings mavonnaise !not low-fat)
Margarine, butter or mayonnaise on bread or
Potatoes
Margarine butter or oil in cooking
Eggs (not egg beaters or ius! egg whites)
Pizza
cheese snre"rl (not low-f"t\
Whole Milk (not skim Y,% or2%\
French fries fried notatoes
Com chins. notato chin.<. noncom
Doughnuts. nastries cake cookies !not low-fat)
Ice cream (not sherbet or non-fat)
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Less than
1 time a
month
month

2-3
times
a
month

1-2
times
a
week

3-4
times
a
week

5 or
more
times
a week

Bariatric Exercise Questionnaire
Over the past month, other than your regular job, how many days per week do you participate
in planned exercise like walking, biking or swimming?
days/week
If you do participate in planned exercise, how many minutes might you spend each time you
engage in planned exercise?
minutes
Does your planned exercise include walking? Yes o

NoD

If yes to walking ...... How many walking sessions per week? _ _ _ __
How many miles walked per session? _ _ _ _ _.miles
Average duration per session?______Minutes?
What is your usual pace of walking? (circle one)
Casual or
Average or
Fairly
Strolling
Normal
Brisk
(<2 mph)
(2 to 3 mph)
(3 to 4 mph)

Brisk or
Striding
(2:4 mph)

What type of activity (if different from walking) did you spend the most time doing during
the past month? (choose one)
Q

Aerobic Dance

miu.

~

min.

u Skflting (icelrolle!)

min.

Q

Backpacking

min.

:: Jogging/numiug

min.

0 Snow skiing

min.

CBadminron

min.

G Jump roping

min.

0 Snorkeling

min.

::JBnskethnll

min.

=Lacrosse

min.

:: Snow shoeing

min.

Bnsebnll

min.

=Life Circuit weights

min.

:J Softball

min.

CBicycling

min.

C Martial At ts

min.

0 Spinning/cycling

min.

::Bowling

min.

:::: Miniature golf

min.

0 Stainnnster

min.

:J Calisthenics

min.

GNnutilus

min.

0 Step aerobics

min.

Q

;::; Canoe/Kayaking

min.

0 Nordic Track

min.

=:! Stretching exercices

min.

:; Cardia glide

min.

UPilates

min.

:! Swimming (laps)

min.

C Cross trainer
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!J Tai Chi
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Horseshoes

Henry Ford Weight Management Program
FOOD DIARY

In order for this to be most useful for the dietitian working with you please pay attention to
the following:
1. EVERYTHING you eat or drink is important to note. Even the smallest item should be
written on this sheet, including dressing, condiments and drink additions, like cream and
sugar. Even write down if you took a bite of something to see how it tastes; or had a
snack from 7-11 or a free sample at the Supermarket; or a hot dog at the hardware store
orK-Mart.
2. Be as specific as you can. Include brand names or restaurant if applicable.
3. Preparation: Include how the food was prepared. If cooked was it baked, broiled, fried,
etc.?
4. Amount Consumed: Although you don't need to measure how much you are eating, do
the best you can to show how much you are eating. Example: 3 cookies, a baseball size
portion of rice, or a piece of meat the size of a deck of cards.
5. Associated Activity: Identify what you are doing while eating, like watching TV, reading
or working at a computer, or simply eating at mealtime.
6. Mood: Identify how you feel when you eating. Are you happy, sad, angry, depressed,
non-emotional, etc.
7. Hunger Rating: Using a scale from 1 (not hungry) to 5 (very hungry), describe how
hungry you feel.
8. REMEMBER: Document the items you eat, not the foods you think the dietitian wants
you to eat.
9. Look at the examples below to help you complete your food diary.
I 0. Choose 3 days to write down what you eat. It is usually best to do this on either
Thursday, Friday, Saturday; OR Sunday, Monday, Tuesday.

Tim
e

Food Item And
Preparation

7:00
Orange juice
Clieerios cerea[
7:00
10:15 Q'opcom

12:30 Jfam ana Clieese
sand"wicli from 7-11
12:30 Co/is <Big Cju{p
12:30 {[)orito's
4:00 <Ba[[(['arfi...liot aog on a
6un-griCCea
Cliocofate
sliafis from
4:30
:M c{[)onolif's
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Amount
Where Are
Consum
You Eating
ed
'Kjtclien
1 cup
1 Y, cups 'Kjtclien
Sma[[6ag 'lJieater

1

In car

44 oz.
Sma[[6ag
1

In car
In car
;u liaraware
store
}!t liome witli
fi.jrfs

:Mecfium

Associated
Activity

Mood

Runge
r
Rating
tirea
3
'Tire a
3
Prustrat 2
ed"

'Eating 6realifast
'Eating 6realifast
Watcliing a
movie witli tlie
fi.jrfs
{[)riving

Jfurried"

4

{[)riving
{[)riving
Sliopping

Jfurried"
Jfurried"
J{appy

4
4
3

Watcliing 'lo/
witli fi...id"s

<Borea

2

Henry Ford Weight Management Program
FOOD DIARY

Name: _ _ _ _ _ _ _ _ _ ___

Date: _ _ _ _ __

NU[N: __________________

Time
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Food Item And
Preparation

Amount
Consumed

Where Are
You Eating

Associated
Activity

Mood

Hunger
Rating

Muscular Strength Data Sheet
Preventive Cardiology
Henry Ford Heart & Vascular Institute
Henrv Ford Hospital
Date:

Subject Number:
Name:

Time of day:

MRN:

I DOB

Age

I MUAC (em):

I Wt:
o No

Medications: oyes

I Gender

Thiqh Circ icm):

Ht:

M/F

Time taken:

BP:
Baseline

Test:
HR:

'
NuStep .Warm
Up
Stage
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•

Spee~

.....

. Time.

:

-'~

.

:

6 Month
.

:

Arms:
.

··. . ·.

. Comments· .. ···•

.··.

.·

3 Month

.> ··_Seat
back:
: ·· -·
·

· -· ;<Fr~~ -:..:··· l~f:> .
· .. ·

.

Leg:

.....

Lateral: •· : · .. · ·• .
.·

·:·

:

.· .

.

.. ··.•.. ·.·•····

· ..

Comments

· •.. <

.

60
120
180
not included)
*'**TWCJ minute rest time between attempts····· (warm:up
.
. ..
Settini\5: SeaL ··-.. Arms: ··· ··
. . ·•
.··
.. ·.·
.·•.
.··....
•. · ·.·
RPE
Comments
.
.:._
'.
. ·: :. .

1 Rep Max/Chest Press·
Att~mpt

.··.· s

Poun
ds

...

. .

:;.

.·

Warm
up

1
2
3
4

5
Do you participate in resistance/weight training?
If yes how often? 0-1 days/wk

2-3 days/wk

4 or more days/wk

How would you describe your program: Upper body only
total

Lower body only

Total body

Alternatin~

How many repetitions?
How many sets?
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8 to 11

Less than 7
One

Two

12 to 15
Three

more than 15
Four

More than four

HENRY FORD HEALTH SYSTEM INSTITUTIONAL REVIEW BOARD
Continuation/Final report form
The IRB is responsible for the continuing review of research to ensure that the rights and welfare of human
participants are being protected. This application for renewal of approval or final report must be submitted to the
Research Administration (IRB) Office by the published deadline date at least one month prior to the expiration date
to guard against lapse in IRB approval.
EXPIRED RESEARCH: If you have not responded in time to renew the protocol before it lapses, the protocol
is considered expired. Any research activity conducted under an expired protocol is in violation of federal
regulations, and could jeopardize the Health System's privilege to conduct human research. The federal
regulations allow no "window" after the expiration of the approval period. It is important that your protocol
be renewed on time. If your approval expires and you wish to continue your research, the protocol may
have to undergo IRB review again as a new protocol. Timely renewal avoids approval/apses.
The IRB must determine from the information provided on this form whether or not this study should be approved to
continue. Per Federal regulations, "'continuing review of research must be substantive and meaningful." Insufficient
information may result in a delay in approving continuation of your project. If this study is part of a multi-center
project. provide data on HFHS subjects separately from national data but include both when available.

DIRECTIONS FOR FORM COMPLETION:
1.

Use this form for all continuation or final reports. Tab through the form, entering your information in the
spaces provided.

2.

E-mail this completed form and consent formls (if still recruiting subjects) to: research_admin@hfhs.org
You must follow these directions:
•

•

•

3.

The e-mail subject line must be in the following format (with underscore):
a.
Indicate 'IRB continuation' or 'IRB final'
b.
PI last name
c.
HFHS IRB#
d.
Indicate 'expedited' or 'full'
e.
Example: 'IRB continuation_Jones_123_full' or 'IRB final _Jones_123_expedited'
Attach the continuation/final report form saved with a title of: PI last name and IRB number (i.e.
'jones_123'). Note use an underscore between the items.
If applicable: attach the consent saved with PI last name, IRB number and 'ICF' (i.e. 'jones_123_1CF)
as the title. If there is more than one consent form, differentiate them by number (ICF_1, ICF_2,
ICF_3, etc.) or other obvious way (ICF_main study, ICF_genetic_substudy) (use an underscore
between the items).

Your forms will be returned to you by e-mail. You may print them for your records as you will not be
receiving copies through interdepartmental mail. As always, should you need a copy, the IRB maintains
paper files for every study.

AI/IRB forms are available on our website (.http://henrv.hfhs.orqlbodv.cfm?id=7764 ).
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Continuation/Final Report
All submissions must be sent electronically to: research_admin@hfhs.org
Investigators are responsible for utilizing the most current versions of IRB
forms and the IRB has the authority to refuse out of date forms.

Institutional Review Board

Please Indicate: ~Continuation

I SECTION 1

D

Final Report

INVESTIGATOR INFORMATION

Principal Investigator (PI): Dennis John Kerrigan
Department (select from the drop downs): Internal Medicine

Division: Cardiology

Entire Project Title (no acronyms): Short-Term Muscular Strength Changes in Patients Following Weight Loss
Surgery. A Pilot Study
IRB #.: 7301 Current IRB Approval Period: 2111/2012-2/11/13
Location to send correspondence (required): WCFCAM
Contact Person: Dennis Kerrigan

Contact phone#: 313-972-4077

Contact e-mail: dkerrig1@hfhs.org

Current source of funding: Internal Is this study currently NIH funded? ~ No DYes (grant#
If yes, was it originally submitted as such? ~ No (if no, submit copy of grant) D Yes
Current budget period (if federally funded):

Title of NIH grant (if different):

THE REST OF THIS PAGE IS FOR IRB USE ONLY
Type of IRB Review:
~Full Board
D Expedited (all expedited continuation & final reports are reviewed
as informational items at fully convened IRB meetings)

APPROVAL STAMP

APPROVAL PERIOD

Result of IRB Review:

Feb 12,2013- Feb 11,2014

~ Continuation Approved

D Approval Withheld (see reason below)
D Final Report Approved (Closure#

INSTITUTIONAL REVIEW BOARD

The HFHS IRB has read & reviewed this protocol & finds this research is appropriate in design and meets the
requirements of the Federal Guidelines, 45 CFR Part 46 and 21 CFR Part 50.

Date: 2112/13

Abstentions:
Comments:
Action required:
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I SECTION 2

UPDATE OF PROJECT ACTIVITY

Please provide a brief yet concise protocol summary. Include the purpose, objective, study design, treatment, and
procedures. If you approval period has lapsed, please provide the IRB of how you will prevent this from occurring in
the future and whether or not information was obtained/patients enrolled during the lapse.
Purpose: The purpose of this proposed study is to describe changes in muscular strength and body fat at three
and six months following bariatric surgery.
Study Design: All subjects are recruited from the Henry Ford Hospital Bariatric Programs (i.e. Detroit, West
Bloomfield). Enrollment criteria will include those patients: who have received clearance from their surgeon,
adult's;, 18 years of age, weight max of 450 lbs, and are free of orthopedic, metabolic, or cardiovascular
limitations to exercise. At baseline (T1) (i.e. 1 month before surgery), three months post-surgery (T2), and six
months post-surgery (T3), subjects will visit the William Clay Ford Center for Athletic Medicine to undergo
strength testing assessments. Testing will include a mild intensity 10 minute warm-up on a recumbent stepper
(i.e. NuStep) followed by a familiarization test on both the isokinetic dynamometer (I D) (Biodex, Shirley, New
York) and an isotonic chest-press (ICP) resistance machine (Cybex). The isokinetic test will measure relative
peak torque (Torque/body mass) at three different speeds as a measure of leg strength. Subjects will be asked to
perform 15 consecutive maximal leg extentions on the ID using their dominate leg with five minute rest periods
between each speed. Following the ID upperbody strength will be assessed using a seated chest press
machine. This will be done using the one-repetition maximal test, which simply measures how much weight an
individual can push (elbows fully extended) a single time.
To determine the relationship between muscular stength and body composition, we will measure changes to lean
and fat mass on a subset of patients using the Bod Pod.
Statistics: A paired-! test will be used to compare changes in relative strength between the three time periods
(T1, T2, T3). Associations between relative peak torque and potential co-variants will be determined using the
Pearson-correlation-coefficient. Alpha level will be set at 0.05.
Current status of study: (Please place a checkmark adjacent to each relevant statement.)
D
No subjects have been enrolled. If not, please explain why and a plan to increase enrollment:

['gJ

Research is active (please check appropriate box below)

['gJ
D
D
D

D

Research is still open to enrollment
Research is permanently closed to subject enrollment, but study remains active for HFHS subjects
receiving study treatment.
Research remains active for long-term follow-up of HFHS subjects and/or data analysis.
Research remains active for data analysis only or for long-term follow-up of HFHS subjects without
any type of intervention/treatment. This continuation will be reviewed through the expedited
process.

Requesting termination. If so, please explain (i.e., final report, research and data analysis complete, study
never initiated, sponsor request):

D Other:

I SECTION 3
1.
2.

3.

ENROLi.JviENT UPOATE

What is the currently approved number of subjects to be enrolled?:
HFHS: 40 Multicenter (if applicable):
Number of subjects enrolled to date (not including screen failures) at:
HFHS: 21 Multicenter (if applicable):

If your number enrolled to date exceeds your targeted accrual goal, please explain and provide the new number
of subjects approved (you must have had IRB and/or sponsor approval to enroll more than targeted):
a. If yes, did you obtain IRB approval?
D No (submit a planned change form with a request to increase the number of subjects)
DYes
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b.

If yes, did you obtain sponsor approval? D No, not required

D Yes

4.

Number of subjects enrolled since last IRB review:
HFHS:9
Multicenter (if applicable):

5.
6.
7.

For studies that involve chart/medical record review, number of records reviewed: 21
Estimated date of enrollment completion (if complete indicate date of completion): 1/26/14
Cumulative HFH accrual by race/ethnic group since study initiation (this satisfies Federal requirements assuring
equitable distribution of study subjects):

Male
Female
TQTALS:
8.

9.

Caucasian

African Amer

4
14
18

3
3

Hispanic

Asian

TOTALS:

Other

4
17

Is there an equitable distribution of ethnic and gender groups? 1ZJ No DYes
If no, provide justification for the inequity. The majority of patients who elect to have bariatric surgery
are female.
If this study has a low accrual rate to date, please explain why the accrual rate is not what was anticipated
(indicate obstacles encountered in enrolling patients):

Have any procedural changes in the protocol been implemented since the study was last approved?
D No 1ZJ
Y es, 1
'f so prov1'd e a conc1se
. narra!'1ve summary exp1a1mng
I . . th e reasons f or the c hange:
Procedural/Planned Change (list all
versions separately, using attached
Date of
IRB
Concise Narrative Summary
additional pages as necessary)
Approval
Addition of Bod Pod test to measure body fat.
Protocol amendment
4-24-12
Revised Informed Consent'
Addition of Bod Pod test to measure body fat.
4-24-12
Advertisement
Investigator Brochure
Sponsor notifications
Data Safety Monitoring Report
Other: please specify
..
• Note: No consent form reviSions can be made 1n conjunction With th1s report. Consent rev1s1ons must be
submitted separately on a Planned Changes form.
Has any new information become available since the last IRB annual review that was disclosed to enrolled
subjects? D No DYes, if so please provide a concise narrative summary explaining the reason(s):

Source of Information
Patient Letter
Revised Informed Consent
Addendum to consent form
Verbal Communication
Other: please specifY

I SECTION 5

Date of
IRB
Approval

Concise Narrative Summary

SUBJECT WITHDRAWALS

Has any HFHS subject been withdrawn (i.e., patient does not fulfill the requirements of the protocol?) for any reason
after signing a consent form?
1ZJ Yes D No
If yes, please indicate the reason for withdrawal and the total number of withdrawn patients:
continuationlfinal 0212012

1

Screen failure
_ _ Patient request
£
Patient non-compliance

Physician discretion
Death
Patient's medical status

Treatment toxicity
Disease Progression
Other (specify):

Please provide additional information if appropriate:

I SECTION 6

SUMMARY OF RESULTS TO DATE

1.

If this is a HFHS PI initiated study, are there any pertinent preliminary results available associated with the
study? 1Zl No D Not a PI initiated study DYes (please attach to this report).

2.

Has this study been audited in the past year by external auditors, not including routine monitoring (i.e. sponsor,
DYes 1Z1 No
FDA)? If so, please submit a copy of the report with this continuation/final report.

3.

Please provide a list of clinically significant protocol deviations in the last year, as determined by the
investigator, and subject complaints and the processes put in place to prevent their recurrence.

4.

Please describe the means whereby the results of the research are going to be disseminated. Peer-reviewed
journals, scientific meetings.

5.

Clinical Trial Registration: Has the study been registered with ClinicaiTrials.gov? The PI is responsible for
determining that registration requirements are met. Normally, the clinical trial will be registered by the sponsor,
lead site (in multi-center studies) or Institute funding the research (in NIH sponsored trials). Refer to the FAQ
section of the IRB website for more details.

D Yes

1Z1

No If no, please explain: Small pilot

study.

Since the last review, have there been any unanticipated problems or serious adverse events encountered in HFHS
subjects that meet the HFHS IRB criteria for Adverse/unexpected events? (If yes, document in summary table
below)
D Yes 1Z1 No
Since the last review, have you received and reviewed one or more reports of adverse drug reactions or other
adverse events from the Sponsor that meet the HFHS IRB criteria for Adverse/unexpected events? (If yes,
document in summary table below)
DYes IZI No
Number of events by body system

Body system

#HFHS
patients in
previous
year

#non- HFHS
patients in
previous year

Total# events
(HFHS & non-HFHS) in
the previous year
(add column 1 & 2)

Total# events
(HFHS & non-HFHS)
since study start

Allergy/Immunology
Cardiovascular
Dermatological
EENT
Endocrine/metab
Gl
Hepatic
Hematological
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Infection
MaliQnancy(1°or2°)
Musculoskeletal
Neurological
Pain
Pulmonary
Renai/GU
Other

I SECTION 8

ALL OF THE ABOVE REPORTS MUST BE SUBMITTED TO
THE IRB PRIOR TO THIS CONTINUATION/FINAL REPORT.
IF THEY HAVE NOT, PLEASE SUBMIT IMMEDIATELY.
PRIVACY

1. Where are the names of research subjects kept? On a password protected HFHS drive
2.

Where are signed original consent forms kept? In a lock file cabinet

3.

What provisions do you have in place to ensure confidentiality of data? Once all data collection is complete
all HIPAA patient identifiers will be removed and the database will be closed. All paper documents
will be discarded in a HIPAA compliant process

I SECTION 9

coNFLICT OF INTEREST

Principal Investigator: Do you, any member of your family, or any person affiliated with the project have any
financial interest, financial relationship, or administrative affiliation with any entity that is providing funds or which
has rights to intellectual property resulting from this study?

[8J No

DYes

If yes, please explain.

IF THIS IS A FINAL REPORT, DO NOT COMPLETE THE REST OF THIS FORM

I SECTION H)

P~RSONNEL UPDATE (Continuation reports only)

List Key Personnel:
Name
1
Carlin, Arthur

Title
Co-PI

2

Genaw, Jefferey

Co-PI

3

Szymanski, Wanda

RN/BSN/CBN

4

Walton, Renee
Rashid, Lewis

Research Assistant
Research Assistant

5

Dept/Division
Gen.
Sur!lerv/Bariatrics
Gen.
Suraerv/Bariatrics
Gen.
Suraerv/Bariatrics
Int. Med/ Cardiolo!lv
Gen.
Sur!lerv/Bariatrics

6
7
8
Have there been changes to Key Personnel since last approved?
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~No
DYes (provide letters of commitment) and explain changes.

I SECTION 11

CURRENT RISK/BENEFIT ASSESSMENT (Continuation reports only)

Have you become aware of any change in the risk/benefit assessment that would affect a patient's willingness to
continue participation in the study?
DYes ~No If yes, please explain:

I SECTION 12

CONSENT SUBMISSION (Continuation reports only)

For continuation reports, the consent form will be stamped with an approval period that matches the approval of
this continuation report. No consent forms should be greater than one year old.
Is a copy of the current unstamped consent document being submitted with this application?
~Yes . Is it the most recently approved version with the 'approval stamp' box left blank?
~Yes

D No

D No/Not applicable, if so
D
D
D

1

please identify reason:
Written consent not required (waived originally)
Study closed to subject enrollment
Other (please explain):

!?~CTI<?N 13 PRINC!PAL.INvt=sriGATOR'$ Assl)RANcJ;
By submitting this application with my name on it I am bound by these obligations:
•
o

o
o
o

o
o
o

o

This application for continuing/final review is complete and accurate
The research will be performed under the direction of the Principal Investigator by trained and qualified
personnel
Informed consent and HIPAA authorization from subjects or their legally authorized representative will be
obtained and documented prior to any research activities using the current IRB approved informed consent
Serious, unexpected adverse events or unanticipated problems will be reported to the IRB, as well as any
information that may affect the safe conduct of the research
The IRB will be informed of any proposed changes in the research or informed consent before changes are
implemented, and no changes will occur without prior IRB approval
A continuing/final review application will be submitted to the IRB before the deadline at intervals
determined by the IRB, but not less than once per year, to avoid expiration of IRB approval
A final report will be submitted to the IRB when all research activities have ended
All Co-investigators, coordinators, staff, and students involved in this research will be informed of their
obligations in meeting the above commitments
Comply with all policies and procedures of Henry Ford Health System Institutional Review Board, as well as
with all applicable federal and state regulations and guidelines and Good Clinical Practice guidelines
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DATE:
CONSENT TO
PARTICIPATE IN A
RESEARCH STUDY

MRN:

(HFH IRB form rev: 0212009)

NAME:

APPROVAL PERIOD
Feb 12,2013- Feb 11, 2014

PROJECT TITLE:
Short-Term Muscular Strength Changes in Patients Following Weight Loss
Surgery. A Pilot Study

INSTITUTIONAL REVIEW BOARD

Dennis J. Kerrigan, PhD.
6525 Second Ave.
Detroit, Ml 48202
313-972-1919
1. WHY IS THIS RESEARCH BEING DONE?
You have been asked to take part in a research study because you plan to have bariatric surgery. The
purpose of this study is to describe changes in muscular strength within the first six months following
weight loss surgery. Because muscle loss can occur along with weight loss, this study will help us
determine how much strength (if any) is lost relative to your weight loss and other factors (e.g. exercise,
diet, age, etc.) after surgery and if future studies should look at ways to improve this.
There will be approximately 40 people in this research study at Henry Ford Health System (HFHS).

2. WHAT WILL HAPPEN IF I TAKE PART IN THIS RESEARCH STUDY?
If you participate in this study, you will be tested 3 separate limes for muscle strength and stamina. You
will also be asked to complete two exercise surveys; two nutrition surveys and we will measure the
circumference of your upper arm and thigh.
Your participation in this study will last a total of 7 months. As part of this study, you will have 3 visits to the
William Clay Ford Center for Athletic Medicine to perform the assessments listed below. The first visit will
be done prior to surgery, the second visit is 3 months post surgery and the last will occur at 6 months post
surgery.
During this study you will not be asked to perform any special exercises or training. With regards to that we
suggest you follow the recommendations given to you by the Henry Ford Bariatric Team.
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DATE:
CONSENT TO
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MRN:

(HFH IRB form rev: 0212009)

NAME:

APPROVAL PERIOD
Feb 12,2013- Feb II, 2014

PROJECT TITLE:
Short-Term Muscular Strength Changes in Patients Following Weight Loss
Surgery. A Pilot Study

INSTITUTIONAL REVIEW BOARD

Extra and not experimental:
-Diet and fitness questionnaires. You will be asked to complete 4 questionnaires regarding eating
and exercise habits.
-Limb circumference measurements. Using a standard tape measure we will measure the
circumference of your upper arm and thigh as an indirect way of determining muscle mass.
-A leg muscle strength and endurance test. This standard leg extension test will determine how
much you can lift one time and also how strong your muscles remain over a short time period using a
machine specific for rehabilitation or research purposes. You will be asked to give a maximal effort.
-An upper-body muscle strength test. This standard chest, arms, and shoulder machine will
determine how much you can lift one time using a standard exercise machine that can be found at a
fitness center.
-Vital signs. This will include a standard seated blood pressure and heart rate similar to what is taken
in your doctor's office.
Extra and experimental:
-Body composition test.
On three additional days (before surgery, 3 months, and six months) you will be asked to take a test
using a Bod Pod, which measures the amount of fat tissue and lean tissue in your body.
The Bod Pod is an egg-shaped device which measures your body fat through changes in air
pressure. You will be asked to wear specially fit swim wear and cap (this will be provided) and sit
still in a chamber while a minimum of two tests are performed. Each test requires 50 seconds.
1) Are you willing to go to West Bloomfield Hospital for additional visits to perform the
Bod Pod test listed under extra and experimental?
Yes, I am willing to return to the lab to perform this test; patient initials __
No thanks; patient initials _ __
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3. WHAT ARE THE RISKS OF THE STUDY?
You should tell the person obtaining your consent about any other medical research studies you are
involved in right now.
It is not expected that you will have any complications or discomforts from being in this study .
. While you are in the study, you are at risk for the following side effects:
• Likely
Minor muscle soreness
Tiredness following exercise, especially after the first several sessions
Mild shortness of breath during exercise
•

Less Likely
-Severe fatigue
-Moderate to severe shortness of breath
-Blisters
-Aggravation of orthopedic (muscle, joint, or bone)
-Fainting
-Abnormal blood pressure response
-Disorders of heart beat (too fast or slow or not effective)

•

Rare but serious
-Heart attack or other heart complication
-Death

There may be additional risks or discomforts that are not known at this time.
There may be risks to you or to your unborn child if you are pregnant now or become pregnant within the
time period of this study. Exercise alone is not typically harmful to the mother or the unborn child. However,
the risk to the mother and unborn child are not known in those who are 3 or 6 months post bariatric surgery
who also perform exercise. These risks may include abnormal development of the unborn child. Also, there
could be risks to you or your unborn child that the investigators cannot predict. Because of this, you cannot
be in this study if you are pregnant, breast feeding a child, or trying to become pregnant. You must use
effective birth control measures including condoms and birth control pills (only if advised by your doctor).
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4. WHAT ARE THE BENEFITS TO TAKING PART IN THE STUDY?
You may not be helped by participating in this study. However, others may be helped by what is learned
from this research.

5. WHAT OTHER OPTIONS ARE THERE?

You do not have to participate in this study. Your other choices may include:
•

Participating in regular exercise and muscular strengthening without enrolling in this study.

Talk to your doctor about your choices before you decide if you will take part in this study.

6. WHAT ABOUT CONFIDENTIALITY?
By signing this consent form, you agree that we may collect, use and release your personal and health
information for the purpose of this research study.
We may collect and use:
•
Your existing medical records.
•
New health information created during this study.
We may release this information to the following people:
The Principal Investigator and his/her associates who work on, or oversee the research activities.
•
•
Government officials who oversee research (Food and Drug Administration).
•
Other researchers at other institutions participating in the research.
Once your information has been released according to this consent form, it could be released again and
may no longer be protected by federal privacy regulations.
This consent form, test results, medical reports and other information about you from this study may be
placed into your medical record. Generally, you are allowed to look at your medical record. During the
research study, you will be allowed to look at your research study information that is not in your medical
record.
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HFHS or others may publish the results of this study. No names, identifying pictures or other direct
identifiers will be used in any public presentation or publication about this study unless you sign a separate
consent allowing that use.
This consent to use and release your personal and health information will expire at the end of this research
study.
You do not have to sign this consent to release your medical information and may cancel it at any time. If
you decide not to sign this consent or cancel your consent, you cannot participate in this study. If you notify
us that you wish to stop participating in this study, we may continue to use and release the information that
has already been collected. To cancel your consent, send a written and dated notice to the principal
investigator at the address listed on the first page of this form.

7. WHAT IF I AM INJURED?
There is no federal, state, or other program that will compensate you or pay for your medical care if you are
injured as a result of participating in this study. You and/or your medical insurance may have to pay for
your medical care if you are injured as a result of participating in this study. You are not giving up any of
your legal rights by signing this consent form.
·

8. WHO DO I CALL WITH QUESTIONS ABOUT THE STUDY OR TO REPORT AN INJURY?
Dr. Dennis Kerrigan or his/her staff member has explained this research study and has offered to answer
any questions. If you have questions about the study procedures you may contact Dr. Kerrigan at 313972-1919. To report an injury or medical situation, please contact Dr. Dennis Kerrigan at 313-972-1919. In
the case of an emergency please call 911. Medical treatment is available to you in case of an injury.
If you have questions about your rights as a research subject you may contact the Henry Ford Health
System IRB Coordinator at (313) 916-2024. The IRB is a group of people who review the research to
protect your rights.

9. DO I HAVE TO PARTICIPATE IN THIS STUDY?
No, your participation in this research study is voluntary. If you decide to participate, you can stop at any
time. If this happens, you may be asked to return for a visit for safety reasons. You will get the same
medical care from HFHS whether or not you participate in this study. There will be no penalties or loss of
benefits to which you would otherwise be entitled if you choose not to participate or if you choose to stop
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your participation once you have started. You will be told about any significant information that is
discovered that could reasonably affect your willingness to continue being in the study.

10. WHO ELSE CAN STOP MY PARTICIPATION?
The Principal Investigator, sponsor or your doctor can end your participation in the research study at any
time. If this happens, you may be asked to return for a visit for safety reasons.
11. WILL IT COST ANYTHING TO PARTICIPATE?
We do not expect there to be any additional costs to you if you participate in this study.
12. WILL I BE PAID TO PARTICIPATE?
No, there will not be any compensation to participate in this study. However, you will be offered a free
monthly membership into the Henry Ford PREVENT exercise program or a free personal training session
at a Henry Ford facility. The free month of PREVENT and free personal training will be offered regardless if
you decide to decline completion of the study following the first test. Additionally, we will provide you with
feedback regarding your results in this study and our recommendations for exercise.
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13.

CONSENT
You have read this consent form or it has been read to you. You understand what you are being asked to
do. Your questions have been answered. Any technical terms you did not understand have been
explained to you. You agree to be in this study. You will be given a copy of this consent form.

Signature of Subject

Date

Time

Date

Time

Print Name of Subject

Witness to Signature

Print Name of Person Obtaining Consent
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